Eagle Pharmaceuticals Inc. (EGRX) 37.63 $EGRX 5 Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Eagle Pharmaceuticals Inc. (EGRX) 37.63 $EGRX

5 Stocks With Jaw-Dropping Growth Potential
George Budwell, The Motley Fool - Motley Fool - Sat Feb 28, 8:04AM CST
With the U.S. stock market hitting record highs of late and red hot sectors like health care sporting some jaw-dropping premiums, it's getting harder and harder to find stocks with compelling valuations. That being said, there are still a handful of...
VRX: 198.71 (-5.24), FLML: 15.37 (-0.78), PTX: 11.78 (+0.28), AZN: 66.27 (-1.91), TEVA: 56.40 (-0.11), GSK: 46.73 (-0.87), EGRX: 37.63 (-0.37), SNY: 47.42 (-0.94), ARDX: 15.66 (-0.42), IG: 9.01 (-0.42)

Nasdaq stocks posting largest volume increases
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
LARK: 26.24 (+0.27), CLSN: 2.82 (-0.05), SBBX: 10.87 (-0.18), NDLS: 17.49 (-0.58), HOTR: 2.04 (-0.03), EGRX: 37.63 (-0.37), ONVI: 4.50 (unch), JAXB: 10.59 (-0.11), BWFG: 19.24 (+0.74), FBSS: 16.70 (-0.85)

Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
RESN: 11.82 (+0.77), UIHC: 23.41 (-0.24), UEIC: 55.16 (-0.70), ALDX: 10.52 (+0.02), AXDX: 18.15 (+0.21), ANGI: 6.80 (+0.08), VNDA: 10.47 (-0.24), FUEL: 10.34 (+0.02), NDLS: 17.49 (-0.58), NMIH: 7.32 (-0.08), EGRX: 37.63 (-0.37)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 11:45AM CST

BNSO: 1.45 (-0.01), BONE: 3.44 (-0.24), FUEL: 10.34 (+0.02), ASTI: 1.43 (-0.02), AHS: 20.93 (-0.22), AXN: 1.49 (+0.37), EGRX: 37.63 (-0.37), NBG: 1.43 (-0.08), GTT: 16.27 (-0.18), WBAI: 14.50 (+0.70), GENE: 4.86 (-1.39), EGLT: 14.05 (-1.13), SAAS: 10.97 (-0.52), CLRX: 1.15 (-0.10), CAS: 3.40 (-0.05), NDLS: 17.49 (-0.58), TRUE: 16.84 (-0.33), HOTR: 2.04 (-0.03), SZMK: 7.75 (-0.47), BLDR: 6.06 (+0.10)

Traders smitten with tiny thinly-traded biotechs
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:44AM CST

GENE: 4.86 (-1.39), HTBX: 7.35 (+0.53), SGNL: 2.70 (-0.11), ROSG: 3.24 (-0.04), TTPH: 37.09 (-1.80), ONCY: 0.90 (-0.15), CLRX: 1.15 (-0.10), MELA: 1.83 (+0.02), AKAO: 10.32 (-0.11), WGBS: 4.71 (-0.03), EGRX: 37.63 (-0.37)

Teva to Commercialize Eagle's Cancer Drug in the U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 12:20PM CST
Teva (TEVA) signed a deal to commercialize Eagle's bendamustine hydrochloride rapid infusion candidate in the U.S.
IPXL: 39.08 (-1.00), ACT: 289.92 (-5.78), TEVA: 56.40 (-0.11), EGRX: 37.63 (-0.37)

Eagle Pharmaceuticals incurs higher net loss of USD5.5m for three month period ended 31 December 2014
M2 - Wed Feb 18, 6:49AM CST
Pharmaceutical company Eagle Pharmaceuticals (NasdaqGM:EGRX) disclosed on Tuesday that it recorded a net loss of USD5.5m (USD0.39 per basic and diluted common share) for the transitional three-month period ended 31 December 2014 (the stub period).
EGRX: 37.63 (-0.37)

Eagle Pharmaceuticals reports 4Q loss
Automated Insights - Wed Feb 18, 4:03AM CST
WOODCLIFF LAKE, N.J. (AP) _ Eagle Pharmaceuticals Inc. (EGRX) on Wednesday reported a loss of $5.5 million in its fourth quarter.
EGRX: 37.63 (-0.37)

Eagle Pharmaceuticals beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 3:44PM CST

EGRX: 37.63 (-0.37)

Eagle Pharmaceuticals, Inc. Reports Financial Results for Three Month Period Ended December 31, 2014
Business Wire - Tue Feb 17, 3:02PM CST
Eagle Pharmaceuticals, Inc. ("Eagle" or "the Company" (Nasdaq:EGRX) today announced its financial results for the transitional three-month period ended December 31, 2014 (the "stub period" . This stub period resulted from the previously-announced change in Eagle's year end from September 30 to December 31. The company will report financial results of the first quarter of 2015 in May.
EGRX: 37.63 (-0.37)

Why Shares of Eagle Pharmaceuticals Inc. Ripped Higher
George Budwell, The Motley Fool - Motley Fool - Tue Feb 17, 12:31PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  Shares of developmental-stage biopharma  Eagle...
TEVA: 56.40 (-0.11), EGRX: 37.63 (-0.37)

Eagle and Teva team up in blood cancer
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 9:05AM CST

TEVA: 56.40 (-0.11), EGRX: 37.63 (-0.37)

Eagle Pharmaceuticals to Hold Conference Call at 8:30 a.m. EST Today to Discuss Licensing Agreement with Teva to Commercialize Eagle's Rapid Infusion Bendamustine
Business Wire - Tue Feb 17, 6:05AM CST
Scott Tarriff, President and Chief Executive Officer of Eagle Pharmaceuticals, Inc. ("Eagle" or "the Company" (Nasdaq:EGRX), will hold a conference call to discuss its newly-disclosed license agreement with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) for EP-3102, Eagle's bendamustine hydrochloride (HCl) rapid infusion product. Interested parties may access the call as follows:
TEVA: 56.40 (-0.11), EGRX: 37.63 (-0.37)

Teva and Eagle Pharmaceuticals Announce Teva's License to Commercialize Eagle's Bendamustine Rapid Infusion Product
Business Wire - Tue Feb 17, 6:01AM CST
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) today announce that the companies have entered into an exclusive license agreement for EP-3102, Eagle's bendamustine hydrochloride (HCl) rapid infusion product for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL). Teva will be responsible for all U.S. commercial activities for the product including promotion and distribution. Eagle has responsibility for obtaining all regulatory approvals, conducting post-approval clinical studies, if required, and initially supplying drug product to Teva.
TEVA: 56.40 (-0.11), EGRX: 37.63 (-0.37)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 112

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 97

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 78

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
VIO Med Spa’s Black Friday Event: Aesthetic Savings

Updated Category News Views 202

Kicking Off the Holiday Season with a Glow Just when you think the holiday hustle can't get busier, VIO Med Spa is opening the gates of rejuvenation just in time to add yourself to that epic list. Starting November 16, VIO launches its Black Friday extravaganza—a deal-laden kick-off that means smooth skin and sharper looks are up for grabs. Member Benefits and Public...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 55

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 204

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 97

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 173

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
ArcSpan AMS Nabs Top Honors at The Wires 2026

Updated Category News Views 97

ArcSpan Takes Center Stage with Prestigious Accolade ArcSpan just bagged the Best New Product or Service: Sell Side award at The Wires 2026. This ain't your average pat on the back. Taking place at the ritzy One Marylebone in London, this win springs from an event that celebrates the crème de la crème of digital advertising innovation. A Solid Win Amid The Changing Ad...

Continue Reading

Top 5 Most Recently Viewed Articles

Pivot Point Consulting Triumphs as KLAS Leader for IT Services

Updated Category News Views 146

Pivot Point Consulting Recognized as a Leader in Managed IT Services For three consecutive years, Pivot Point Consulting has earned the prestigious title of #1 Best in KLAS: Managed IT Services. This recognition, based on outstanding client feedback, highlights their ongoing commitment to excellence in the healthcare IT sector. The Significance of KLAS Rankings KLAS...

Continue Reading
Revolutionizing Intelligent Vision: Leopard Imaging's New Offerings

Updated Category News Views 203

Revolutionizing Intelligent Vision Solutions Leopard Imaging Inc., a pioneering company in intelligent vision technology, has unveiled its groundbreaking high-resolution RGB-IR stereo camera series, known as Eagle. This series is powered by two of the most advanced technologies from NVIDIA: Holoscan and Jetson Thor. As a leading innovator in the realm of intelligent...

Continue Reading
Gartner's CEO Eugene Hall Executes Major Stock Sales

Updated Category News Views 320

Eugene Hall's Major Stock Sales at Gartner Gartner Inc. (NYSE: IT) is in the spotlight following a significant stock sale by its Chairman and CEO, Eugene A. Hall. This recent move, detailed in an SEC filing, shows that Hall sold shares worth a considerable total of $17,213,808. Overview of Hall's Stock Transactions Hall's stock sales occurred over several transactions,...

Continue Reading
How Canadian Tariffs Could Impact These 5 Companies

Updated Category News Views 1409

Understanding the Potential Impact of Canadian Tariffs The announcement of possible tariffs on Canadian imports has taken many businesses by surprise, igniting a wave of concern across multiple sectors. Companies are now racing to reassess their strategies as new cost structures could potentially shape their futures. What Does This Mean for U.S. Companies? The initiative...

Continue Reading
Holley Performance Brands Launches Major Stock Offering

Updated Category News Views 309

Holley Performance Brands Unveils Secondary Stock Offering Holley Performance Brands (NYSE: HLLY) has recently made headlines by announcing a secondary offering of its common stock, which aims to raise capital and create further investment opportunities for investors. This move underscores Holley's commitment to enhancing its presence in the automotive performance market....

Continue Reading